Cytosorbents Crp (CTSO) — Capital Reinvestment Ratio
Latest as of June 2020:
0.26x
Cytosorbents Crp (CTSO) has a Capital Reinvestment Ratio of 0.26x as of June 2020, meaning it reinvests 0% of its operating cash flow ($1.94 Million) in capital expenditures ($497.36K). See Cytosorbents Crp (CTSO) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
$1.94 Million
USD
Capital Expenditures
$497.36K
USD
Data as of
Jun 2020
Most recent filing
Annual Capital Reinvestment Ratio for Cytosorbents Crp (None–None)
Year-by-year Capital Reinvestment Ratio for Cytosorbents Crp from None to None. For live market cap and broader valuation context, see Cytosorbents Crp market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow